This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Study of Central Monoamine Metabolism and Therapeutic Trial of Levodopa

Jerry R. Mendell, MD; Thomas N. Chase, MD; W. King Engel, MD

Arch Neurol. 1971;25(4):320-325.

Abstract
Cerebrospinal fluid (CSF) levels of homovanillic acid (HVA), a major catabolite of dopamine, were substantially less in 21 patients with amyotrophic lateral sclerosis (ALS) than in 19 controls. There was also a significant reduction in the probenecid-induced accumulation of HVA in the CSF of ALS patients as compared with control subjects. Since probenecid inhibits the efflux of HVA from the central nervous system, the results suggest that central dopamine synthesis may be diminished in ALS. A therapeutic trial of levodopa, the immediate precursor of dopamine, in ten ALS patients failed to improve motor function. Defects in central dopamine metabolism, inferred from these tests applicable to the living patient, evidently may attend neurologic disorders which are unresponsive to precursor loading with levodopa.

Author Affiliations
Bethesda, Md

From the Medical Neurology Branch, National Institute of Neurological Diseases and Stroke (Drs. Mendell and Engel), and the Neurology Unit, National Institute of Mental Health (Dr. Chase), Bethesda, Md.

Footnotes
Accepted for publication April 13, 1971.

Reprint requests to Medical Neurology Branch, National Institute of Neurologic Diseases and Stroke, Bethesda, Md 20014 (Dr. Mendell).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurotransmitter Abnormalities in Patients With Motor Neuron Disease
Belendiuk et al.
Arch Neurol 1981;38:415-417.
ABSTRACT  

Levodopa-Induced Dyskinesias: Comparison in Parkinsonism-Dementia and Amyotrophic Lateral Sclerosis
Chase et al.
Arch Neurol 1973;29:328-330.
ABSTRACT  

Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid
Post et al.
Science 1973;179:1002-1003.
ABSTRACT  

Central Monoamine Metabolism in Parkinson's Disease
Chase and Ng
Arch Neurol 1972;27:486-491.
ABSTRACT  

Serotonergic Mechanisms in Parkinson's Disease
Chase
Arch Neurol 1972;27:354-356.
ABSTRACT  

Huntington's Chorea: Effect of Serotonin Depletion
Chase et al.
Arch Neurol 1972;26:282-284.
ABSTRACT